FDA Inspection 1268969 — Haiyan Tu, MD, MM
The FDA completed an inspection of Haiyan Tu, MD, MM on Apr 25, 2025 in Guangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 25, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Guangzhou (China)
Additional details
Clinical Investigator (CI)